CAF combination chemotherapy in breast cancer patients with liver metastasis

Abstract EN

Background : management modalities for liver metastasis from primary breast cancer are evolving steadily but systemic chemotherapy remains the mainstay of treatment.

Patients and methods: 30 patients with breast carcinoma and liver metastasis managed at (Baghdad teaching hospital) during the period from Jan.

2005 to Jan.

2007.

Results: 16 patients showed response to chemotherapy.

20 % complete response was found and 33 % showed partial response 57 % went into progressive disease.

The duration of response lasted for less than six months in 4 patients and more than six months in two patients.

Conclusion : chemotherapy remains the mainstay of treatment of liver metastasis but new modalities of treatment add much for chemotherapy if used in combination.